If we bring a new medicine to market, it can help patients worldwide,
as opposed to the 20 or so patients we might see in clinic in one day.
That's what drives me. It's the greater impact we can have by working
here at AbbVie.
Kyle Holen, M.D., Vice President, General Medicine and Infectious Diseases
AbbVie combines advanced science, expertise and passion to solve the
world’s most serious health issues and have a remarkable impact on
people’s lives
AbbVie was named to the DJSI World Index for the seventh year in a
row for our responsible economic, environmental and social performance
DiversityInc Top 50 Companies for Philanthropy
AbbVie ranked No. 5 on DiversityInc’s list for 2020. DiversityInc
also recognized AbbVie as one of the Top 50 Companies for Diversity
this year
Seven years on The Civic 50
For the seventh year in a row, AbbVie was named on The Civic 50, a
listing of the most community-minded companies in the United States
1 of 3
2 of 3
3 of 3
slide1
slide3
slide3
You are about to leave the AbbVie website
The product-specific site Internet site that you have requested is
intended for the residents of a particular country or countries, as
noted on that site. As a result, the site may contain information on
pharmaceuticals that are not approved in other countries or region. If
you are a resident of a country other than those to which the site is
directed, please return to AbbVie.com or contact your local AbbVie
affiliate to obtain the appropriate product information for your country
of residence. The Internet site that you have requested may not be
optimized to your screen size. Do you wish to continue to this
product-specific site?
The link below will take you out of the AbbVie family of websites.
Links which take you out of the AbbVie worldwide websites are not under
the control of AbbVie, and AbbVie is not responsible for the contents of
any such site or any further links from such site. AbbVie is providing
these links to you only as a convenience and the inclusion of any link
does not imply endorsement of the linked site by AbbVie. The Internet
site that you have requested may not be optimized to your screen size.
Do you wish to leave this site?
Recommended Offer for Allergan plc (“Allergan”) by AbbVie Inc.
(“AbbVie”) (the “Acquisition”) by means of a scheme of arrangement under
Irish law (the “Scheme”). You are attempting to enter the section of
this website that is designated for the publication of documents and
information in connection with the offer by AbbVie for Allergan
announced on June 25, 2019 (the “Offer”). ACCESS TO THIS SECTION OF THE
WEBSITE MAY BE RESTRICTED UNDER SECURITIES LAWS IN CERTAIN
JURISDICTIONS. THIS NOTICE REQUIRES YOU TO CONFIRM CERTAIN MATTERS
(INCLUDING THAT YOU ARE NOT RESIDENT IN SUCH A JURISDICTION), BEFORE YOU
MAY OBTAIN ACCESS TO THE INFORMATION. THE INFORMATION IS NOT DIRECTED
AT, AND IS NOT INTENDED TO BE ACCESSIBLE BY, PERSONS RESIDENT IN ANY
JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT
LAWS OF THAT JURISDICTION. IF YOU ARE NOT PERMITTED TO VIEW THE
INFORMATION, OR VIEWING THE INFORMATION WOULD RESULT IN A BREACH OF THE
ABOVE, OR YOU ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW
THE INFORMATION, PLEASE EXIT THIS WEBPAGE. THIS SECTION OF THE WEBSITE
CONTAINS ANNOUNCEMENTS, DOCUMENTS AND INFORMATION (TOGETHER THE
"INFORMATION") RELATING TO THE OFFER IN COMPLIANCE WITH THE
IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES 2013 (THE "IRISH
TAKEOVER RULES"). THE INFORMATION IS BEING MADE AVAILABLE IN GOOD
FAITH AND FOR INFORMATION PURPOSES ONLY, AND ITS AVAILABILITY IS SUBJECT
TO THE TERMS AND CONDITIONS SET OUT BELOW. THE INFORMATION IS NOT
INTENDED TO, AND DOES NOT, CONSTITUTE OR FORM ANY PART OF AN OFFER TO
SELL OR OTHERWISE DISPOSE OF OR AN INVITATION OR THE SOLICITATION OF AN
OFFER TO PURCHASE OR OTHERWISE ACQUIRE ANY SECURITIES, OR THE
SOLICITATION OF A VOTE OR APPROVAL PURSUANT TO THE INFORMATION OR
OTHERWISE. ANY PERSON SEEKING ACCESS TO THIS SECTION OF ABBVIE’S WEBSITE
REPRESENTS AND WARRANTS TO ABBVIE THAT THEY ARE DOING SO FOR INFORMATION
PURPOSES ONLY. BASIS OF ACCESS TO INFORMATION Please read this notice
carefully before clicking "I agree" or "I disagree"
below. This notice applies to all persons who view this section of the
website and, depending on where you live, it may affect your rights.
This notice may be amended or updated by AbbVie from time to time and it
should be read carefully in full each time you wish to view the website.
In addition, the content of the website, and its accessibility by
certain persons, may be amended at any time in whole or in part at the
sole discretion of AbbVie. The Information speaks only at the date of
the relevant document or announcement and AbbVie has, and accepts, no
responsibility or duty to update any Information (other than to the
extent such duty arises as a matter of law or regulation).
